MPA

October Handout

October 13, 2017

Leading Change: Efforts to Improve Patient Care and Advance Pharmacy Practice

  • Discuss the purpose and goals of the ASHP Practice Advancement Initiative
  • Discuss opportunities for pharmacists to create value through changes in healthcare payment systems
  • Discuss the value of advancing the roles and responsibilities of pharmacy technicians
  • Describe various changes in pharmacy practice that could help facilitate significant improvements in patient care
  • Describe a vision for the future where pharmacists are the primary prescribers of medications as members of interprofessional healthcare teams
  • 0837-9999-17-116-L04-P

Treating Tobacco Use Disorder

  • Explain the health consequences of tobacco use and benefits of quitting
  • Describe the chronic and relapsing nature of tobacco use disorder
  • Describe evidence-based methods for brief interventions for treating tobacco use disorder
  • Explain the correct use, efficacy, adverse events, contraindications, known side effects and exclusions for all first-line tobacco treatment medications
  • 0837-9999-17-114-L01-P

Maine Legislative Update, 128th Maine Legislative Session I, 1/4/17 – 8-2-17

  • Identify new drugs that can be dispensed by pharmacists following law enactment 2017
  • Describe the steps a pharmacy bill submission takes through law enactment and ultimately becomes practice ready
  • Recognize the difference between a pharmacy law and a pharmacy rule
  • 0837-9999-17-101-L03-P

Effectively Managing Crucial Conversations

  • Define Crucial Conversations
  • Recall the two common downfalls of most communication
  • Recognize the signs that your conversation is falling apart
  • Identify tools that can be utilized to put your conversation back on track
  • Apply concepts to enhance a move to action
  • 0837-9999-17-088-L04-P

Beam Me Up: Precepting the Next Generation

  • Describe the characteristics, learning styles, motivators, and value structures of learners of each generation
  • Identify challenges and opportunities in Precepting the next generation of learners
  • Identify methods to adapt your current Precepting techniques to meet the learning needs of millennials
  • 0837-9999-17-113-L04-P

Medical Marijuana Point-Counterpoint

  • Describe the pharmacology and pharmacokinetics of cannabinoids
  • Identify the currently known adverse effects and efficacy of cannabinoids
  • Review the clinical indications for the use of medical cannabis
  • Recall the safety profile and drug interactions of medical cannabis
  • Discuss the common forms of administration of medical cannabis and the advantages of them in clinical practice
  • 0837-9999-17-120-L01-P

CPR Re-certification

  • Describe the chain of survival with the application of basic life support concepts
  • Demonstrate/perform high-quality CPR for an adult, child, and infant
  • Describe the technique for relief of foreign-body airway obstruction
  • Demonstrate the multiple techniques used for adult and infant relief of foreign-body airway obstruction
  • Describe and demonstrate multirescuer CPR
  • Describe and demonstrate appropriate use of an AED
  • 0837-9999-17-122-L01-P

October 14, 2017

Expanding the role of Pharmacists = Expanding Patient Access to Care

  • List the details of federal provider status legislation and recent activity
  • Explain state-level opportunities that may increase patient access to pharmacists’ services
  • Describe how success at the federal and state level can impact pharmacists and their practice
  • Discuss ways to advocate and get involved
  • 0837-9999-17-115-L04-P
  • List the details of federal provider status legislation and recent activity
  • Recognize state-level opportunities that may increase patient access to pharmacists’ services
  • Recall how success at the federal and state level can impact pharmacists and their practice
  • Discuss ways to advocate and get involved
  • 0837-9999-17-115-L04-T

USP <797> and <800> Update

  • Recall the status of the USP Compounding chapters
  • Explain the types of facilities required for sterile compounding and for hazardous compounding
  • Define the types of environmental monitoring required for sterile and hazardous compounding
  • Restate the document and must be used to develop your hazardous drug list
  • List three alternative containment strategies and/or work practices that can be used to mitigate risks of hazardous drugs that are not antineoplastics
  • 0837-9999-17-089-L07-P
  • Recognize the USP compounding chapters that are official now, and those that will be official within the next year
  • Restate the two types of IV rooms where compounded sterile preparations can be mixed
  • List the two required environmental monitoring tests required by USP <797>
  • Restate the organization that maintains the list of drugs that are hazardous to healthcare personnel
  • Restate the three types of engineering controls required by USP <800>
  • 0837-9999-17-089-L04-T

New Drug Update

  • Define the indications for recently approved prescription medications
  • Recall the mechanism of action and dosing parameters for each new drug
  • Discuss the new drug’s place in therapy
  • Explain key counseling points for each new medication
  • 0837-9999-17-090-L01-P
  • Recall the indications for recently approved prescription medications
  • Recognize the mechanism of action and dosing parameters for each new drug
  • State the new drug’s place in therapy
  • Describe key counseling points for each new medication
  • 0837-9999-17-090-L01-T

A Brief Overview of Pharmacy Calculations for Pharmacy Technicians

  • Discuss and explain ratio and proportion and dimensional analysis methods to solve pharmacy calculation problems
  • Recognize and express units among the pharmacy math systems, especially the metric systems
  • Define and express percentage strength of a medication expressed as weight/weight, weight/volume or volume/volume
  • Discuss and explain parenteral IV flow rate calculations
  • 0837-9999-17-108-L04-T

Immunization Update 2017

  • Discuss the gap between current rates and Health People 2020 goals for vaccinations
  • List each of the CDC recommended flu vaccines based upon live/inactivated, route, prep., and storage.
  • Discuss the influenza vaccines for 2017 including the new quadrivalent and mammalian cell vaccines
  • Identify vaccine contraindications and recommend vaccines based upon age and medical history
  • Explain ACIP recommendations and FDA approved indications for the CDC recommended vaccines
  • Recognize federal and state laws that regulate vaccine administration
  • 0837-9999-17-117-L06-P

Advancing the Roles for Pharmacy Technicians in an Evolving Health Care Environment—PART 1

  • Describe the evolving national health care landscape and how it serves as the framework for pharmacy technician role/responsibilities expansion
  • Describe examples of expanded roles and responsibilities for pharmacy technicians and how they may provide opportunities for patient care services advancement, patient safety initiatives enhancement, and pharmacist/pharmacy technician job satisfaction
  • Explain how state pharmacy regulatory variations in pharmacy technician education, training, certification and licensure may support or suppress advanced roles creation for pharmacy technicians
  • Recognize possible pharmacy technician education, training, and certification requirements to assume advanced roles and responsibilities
  • 0837-9999-17-099-L04-T

Advancing the Roles for Pharmacy Technicians in an Evolving Health Care Environment: Pharmacy Technician Stakeholder Consensus Conference—PART-2

  • Describe the history of pharmacy consensus conferences focused on the pharmacy technician workforce
  • Explain the differences between pharmacist and pharmacy technician pathways for entry into the profession of pharmacy and their potential impact on advancing pharmacy technician roles/responsibilities
  • Describe the key recommendations resulting from the Pharmacy Technician stakeholder Consensus Conference (PTSCC) and their significance for the profession
  • Identify which entities bear the responsibility for advancing the conference recommendations into implementable actions
  • 0837-9999-17-100-L04-T

Law Update

  • Recall recent pharmacy-related legislation
  • Apply recent pharmacy-related legislation to pharmacy practice
  • Discuss opioid prescribing and dispensing laws in the State of Maine
  • 0837-9999-17-119-L03-P
  • Recall recent pharmacy-related legislation
  • Apply recent pharmacy-related legislation to pharmacy practice
  • Discuss opioid prescribing and dispensing laws in the State of Maine
  • 0837-9999-17-119-L03-T

October 15, 2017

340B Program and Apexus Update

  • Discuss 340B Program policy updates and trends
  • Describe tools and resources available to entities through the Prime Vendor Program to support program integrity
  • 0837-9999-17-097-L04-P

Population Health and Evolving Pharmacy Practice

  • Express WHY population health is important
  • Describe the major healthcare payment reform models in place
  • Describe the importance of population risk
  • Identify the most important quality measures for pharmacy practice
  • Identify one strategy you can use in your day-to-day pharmacy practice to improve the health of populations
  • 0837-9999-17-111-L04-P

Oral Oncolytics: The Expanding Role of the Oncology Pharmacist

  • Identify opportunities and challenges associated with the recent growth of the oral onolytic market
  • Describe various patient care models employed to manage patients on oral oncolytics
  • Define the roles of oncology pharmacists and pharmacy technicians in the management of patients on oral oncolytic treatments
  • Explain the integrated model of a Health-System to justify enhancing patient care through expanded clinical pharmacy services in patients receiving oral oncolytics
  • 0837-9999-17-110-L01-P

How can you Mend a Broken Heart? 2017 Update on Heart Failure

  • Identify the evidence, utility, and limitations of established biomarkers in prevention, diagnosis, and prognosis of heart failure
  • Discuss the mechanism of action, supporting clinical evidence, and appropriate use of the newer chronic heart failure therapies
  • Describe an appropriate, patient-specific, evidence-based pharmacotherapy plan for heart failure management
  • 0837-9999-17-109-L01-P

The Veterinary Pharmacy Marketplace

  • Recall current pet ownership and pet expenditure statistics for companion animals in the United States
  • Explain why the Veterinarian-Client-Patient Relationship is required for a veterinarian to have prescriptive authority
  • Describe the locations from which a client can access pet medications, and how pet medication purchasing trends have affected their business
  • Recall the veterinary pharmacy knowledge and training that community pharmacists experience in the PharmD curriculum, and in practice
  • 0837-9999-17-112-L04-P

CPR Re-certification

  • Describe the chain of survival with the application of basic life support concepts
  • Demonstrate/perform high-quality CPR for and an adult, child and infant
  • Describe the technique for relief of foreign-body airway obstruction
  • Demonstrate the multiple techniques used for adult and infant relief of foreign-body airway obstruction
  • Describe and demonstrate mutirescuer CPR
  • Describe and demonstrate appropriate use of an AED
  • 0837-9999-17-123-L01-P